Literature DB >> 6085173

N-Acetylserotonin in the central nervous system.

G M Brown, O Pulido, L J Grota, L P Niles.   

Abstract

N-acetylserotonin has been identified by immunohistochemistry in specific brain areas separate from melatonin and serotonin. N-acetylserotonin is widely distributed within the brain stem, cerebellum and hippocampus and in the brain stem it is contained within the reticular formation nuclei and motor nuclei. Like serotonin, N-acetylserotonin appears to be derived from tryptophan as tryptophan hydroxylase inhibition leads to a lowering in immunoreactive N-acetylserotonin in brain and blood. Beta adrenergic drugs influence N-acetylserotonin neurons with beta adrenergic agonists causing a rise in immunoreactive N-acetylserotonin. The presence of N-acetylserotonin in brain has been confirmed by gas chromatography, mass spectrometry and radioimmunoassay. At this point little is known of the possible role of N-acetylserotonin in the brain. In the hippocampus N-acetylserotonin is present in granule cells and its appearance parallels the appearance of those cells. High affinity binding of tritiated N-acetylserotonin is found in brain and in various brain areas and this radioligand appears to label serotonergic receptors. Preliminary iontophoretic studies performed on hippocampal slices indicate an inhibitory action of N-acetylserotonin on glutamate induced firing of pyramidal cells. Taken together these findings suggest that N-acetylserotonin may have a role in the central nervous system distinct from that of being a precursor for melatonin. If this hypothesis is correct it would suggest that indoleamines have certain similarities to catecholamines. Thus for the catecholamines, dopamine, norepinephrine and epinephrine form a synthetic sequence and yet have independent roles as neurotransmitters and/or hormones. The three indoleamines serotonin, N-acetylserotonin and melatonin also form a synthetic sequence and these three substances may also have independent roles as neurotransmitters and/or hormones.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6085173     DOI: 10.1016/0278-5846(84)90003-4

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  6 in total

1.  Polymorphisms in melatonin synthesis pathways: possible influences on depression.

Authors:  Daniel F Kripke; Caroline M Nievergelt; Greg J Tranah; Sarah S Murray; Michael J McCarthy; Katharine M Rex; Neeta Parimi; John R Kelsoe
Journal:  J Circadian Rhythms       Date:  2011-08-09

2.  Altered interactions of tryptophan metabolites in first-episode neuroleptic-naive patients with schizophrenia.

Authors:  J K Yao; G G Dougherty; R D Reddy; M S Keshavan; D M Montrose; W R Matson; S Rozen; R R Krishnan; J McEvoy; R Kaddurah-Daouk
Journal:  Mol Psychiatry       Date:  2009-04-28       Impact factor: 15.992

Review 3.  Serotonin-kynurenine hypothesis of depression: historical overview and recent developments.

Authors:  Gregory Oxenkrug
Journal:  Curr Drug Targets       Date:  2013-05-01       Impact factor: 3.465

4.  N-acetylserotonin and aging-associated cognitive impairment and depression.

Authors:  Gregory Oxenkrug; Rebbie Ratner
Journal:  Aging Dis       Date:  2012-06-19       Impact factor: 6.745

5.  N-acetylserotonin activates TrkB receptor in a circadian rhythm.

Authors:  Sung-Wuk Jang; Xia Liu; Sompol Pradoldej; Gianluca Tosini; Qiang Chang; P Michael Iuvone; Keqiang Ye
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-04       Impact factor: 12.779

6.  Protective effect of N-acetylserotonin against acute hepatic ischemia-reperfusion injury in mice.

Authors:  Shuna Yu; Jie Zheng; Zhengchen Jiang; Caixing Shi; Jin Li; Xiaodong Du; Hailiang Wang; Jiying Jiang; Xin Wang
Journal:  Int J Mol Sci       Date:  2013-08-29       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.